iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Short Interest Update

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) was the target of a large drop in short interest in the month of July. As of July 15th, there was short interest totaling 266,083 shares, a drop of 40.0% from the June 30th total of 443,214 shares. Based on an average daily trading volume, of 440,124 shares, the days-to-cover ratio is currently 0.6 days. Currently, 1.9% of the company’s shares are short sold.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of IHE stock opened at $101.62 on Friday. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $64.94 and a fifty-two week high of $105.02. The firm has a market cap of $1.59 billion, a P/E ratio of 17.75 and a beta of 0.49. The business’s 50 day moving average price is $96.99 and its 200-day moving average price is $91.01.

Institutional Trading of iShares U.S. Pharmaceuticals ETF

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Foundations Investment Advisors LLC bought a new position in iShares U.S. Pharmaceuticals ETF in the 4th quarter worth $54,513,000. BNP Paribas Financial Markets bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter valued at about $13,108,000. Anfield Capital Management LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at about $10,007,000. JPMorgan Chase & Co. increased its position in shares of iShares U.S. Pharmaceuticals ETF by 89.4% during the fourth quarter. JPMorgan Chase & Co. now owns 212,805 shares of the company’s stock valued at $18,052,000 after buying an additional 100,426 shares during the period. Finally, Cetera Investment Advisers increased its position in shares of iShares U.S. Pharmaceuticals ETF by 675.4% during the first quarter. Cetera Investment Advisers now owns 109,471 shares of the company’s stock valued at $9,489,000 after buying an additional 95,353 shares during the period.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.